|
H6PD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.756100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.020200E-03 |
| Normal-vs-Stage2 |
2.899600E-02 |
| Normal-vs-Stage3 |
7.703600E-03 |
| Normal-vs-Stage4 |
4.283800E-03 |
| Stage1-vs-Stage2 |
6.675000E-01 |
| Stage1-vs-Stage3 |
8.515000E-01 |
| Stage1-vs-Stage4 |
5.795200E-01 |
| Stage2-vs-Stage3 |
8.034400E-01 |
| Stage2-vs-Stage4 |
9.817200E-01 |
| Stage3-vs-Stage4 |
7.464400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.437770E-02 |
| Normal-vs-AfricanAmerican |
7.553200E-01 |
| Normal-vs-Asian |
2.192200E-02 |
| Caucasian-vs-AfricanAmerican |
1.660430E-01 |
| Caucasian-vs-Asian |
7.377400E-01 |
| AfricanAmerican-vs-Asian |
1.353770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.840400E-03 |
| Normal-vs-Female |
5.422300E-03 |
| Male-vs-Female |
7.650800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.701600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.243500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.497500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.392040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.089800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.718200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.339400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.780400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.513000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.372600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.233400E-01 |
| Classical-VS-Follicular |
1.13410000002201E-06 |
| Classical-VS-Other |
5.243700E-02 |
| Classical-VS-Normal |
9.098300E-02 |
| Tall-VS-Follicular |
5.565800E-02 |
| Tall-VS-Other |
1.407770E-01 |
| Tall-VS-Normal |
3.879700E-02 |
| Follicular-VS-Other |
7.493800E-01 |
| Follicular-VS-Normal |
2.43560000001697E-06 |
| Other-VS-Normal |
1.076120E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.756550E-03 |
| Normal-vs-N1 |
7.989600E-04 |
| N0-vs-N1 |
3.894000E-01 |
|
|
